177 related articles for article (PubMed ID: 8419084)
1. Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia.
Ayehunie S; Sonnerborg A; Yemane-Berhan T; Zewdie DW; Britton S; Strannegard O
Clin Exp Immunol; 1993 Jan; 91(1):37-42. PubMed ID: 8419084
[TBL] [Abstract][Full Text] [Related]
2. Relationship between cell-free viraemia, antigenaemia and antibody levels in HIV-1-infected Ethiopian patients.
Ayehunie S; Sönnerborg A; Desta B; Kefene H; Zewdie D; Britton S; Strannegård O
AIDS; 1992 Jul; 6(7):651-7. PubMed ID: 1503684
[TBL] [Abstract][Full Text] [Related]
3. Immune activation markers to predict AIDS and survival in HIV-1 seropositives.
Fuchs D; Jäger H; Popescu M; Reibnegger G; Werner ER; Dierich MP; Kaboth W; Tilz GP; Wachter H
Immunol Lett; 1990 Oct; 26(1):75-9. PubMed ID: 2125976
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus.
Senaldi G; Peakman M; Natoli C; Hussain MJ; Gallati H; McManus T; Vergani D; Iacobelli S
J Infect; 1994 Jan; 28(1):31-9. PubMed ID: 8163831
[TBL] [Abstract][Full Text] [Related]
5. Regulation of tumor necrosis factor receptor expression by acid-labile interferon-alpha from AIDS sera.
Lau AS; Der SD; Read SE; Williams BR
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):545-52. PubMed ID: 1657073
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
Herold M; Meise U; Günther V; Rössler H; Zangerle R
Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
[TBL] [Abstract][Full Text] [Related]
7. Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1.
Fuchs D; Chiodi F; Albert J; Asjö B; Hagberg L; Hausen A; Norkrans G; Reibnegger G; Werner ER; Wachter H
AIDS; 1989 May; 3(5):285-8. PubMed ID: 2504232
[TBL] [Abstract][Full Text] [Related]
8. Neopterin and alpha and beta interleukin-1 levels in sera of patients with human immunodeficiency virus infection.
Reddy MM; Grieco MH
J Clin Microbiol; 1989 Sep; 27(9):1919-23. PubMed ID: 2789233
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation.
Tilg H; Vogel W; Aulitzky WE; Herold M; Königsrainer A; Margreiter R; Huber C
Transplantation; 1990 Jun; 49(6):1074-80. PubMed ID: 2163132
[TBL] [Abstract][Full Text] [Related]
10. Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation.
Aukrust P; Liabakk NB; Müller F; Espevik T; Frøland SS
Infection; 1995; 23(1):9-15. PubMed ID: 7744500
[TBL] [Abstract][Full Text] [Related]
11. Cytokine network and acute primary HIV-1 infection.
Sinicco A; Biglino A; Sciandra M; Forno B; Pollono AM; Raiteri R; Gioannini P
AIDS; 1993 Sep; 7(9):1167-72. PubMed ID: 8216972
[TBL] [Abstract][Full Text] [Related]
12. Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection.
Sönnerborg AB; von Stedingk LV; Hansson LO; Strannegård OO
AIDS; 1989 May; 3(5):277-83. PubMed ID: 2504231
[TBL] [Abstract][Full Text] [Related]
13. Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users.
Sacktor N; Liu X; Popescu M; Marder K; Stern Y; Mayeux R
Arch Neurol; 1995 Jul; 52(7):676-9. PubMed ID: 7619023
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group.
Dezube BJ; Pardee AB; Chapman B; Beckett LA; Korvick JA; Novick WJ; Chiurco J; Kasdan P; Ahlers CM; Ecto LT
J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):787-94. PubMed ID: 8099612
[TBL] [Abstract][Full Text] [Related]
15. Neopterin augmentation of tumor necrosis factor production.
Barak M; Gruener N
Immunol Lett; 1991 Sep; 30(1):101-6. PubMed ID: 1959936
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection.
Zangerle R; Gallati H; Sarcletti M; Wachter H; Fuchs D
Immunol Lett; 1994 Jul; 41(2-3):229-34. PubMed ID: 8002043
[TBL] [Abstract][Full Text] [Related]
17. Cytokine levels in acute alcoholic hepatitis: a sequential study.
Rodríguez-Rodríguez E; González-Reimers E; Santolaria-Fernández F; Milena-Abril A; Rodríguez-Moreno F; Oramas-Rodríguez J; Martínez-Riera A
Drug Alcohol Depend; 1995 Jul; 39(1):23-7. PubMed ID: 7587970
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters.
Aukrust P; Liabakk NB; Müller F; Lien E; Espevik T; Frøland SS
J Infect Dis; 1994 Feb; 169(2):420-4. PubMed ID: 7906293
[TBL] [Abstract][Full Text] [Related]
19. The in vivo immunomodulatory effects of recombinant interferon gamma plus recombinant tumor necrosis factor-alfa.
Urba WJ; Kopp WC; Clark JW; Smith JW; Steis RG; Huber C; Coggin D; Longo DL
J Clin Oncol; 1991 Oct; 9(10):1831-9. PubMed ID: 1919633
[TBL] [Abstract][Full Text] [Related]
20. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
